[1]
E. Sweed, D. Sweed, N. Galal, and H. I. Abd-Elhafiz, “Dapagliflozin Protection against Myocardial Ischemia by Modulating Sodium-glucose Transporter 2 Inhibitor, Silent Information Regulator 1, and Fatty Acid Synthase Expressions”, Open Access Maced J Med Sci, vol. 10, no. A, pp. 1544–1554, Oct. 2022.